Photos are not representative of an actual patient. For demonstrative purposes only. All photos are used with permissions.
References: 1. Clark RH. The epidemiology of respiratory failure in neonates born at an estimated gestational age of 34 weeks or more. J Perinatol. 2005;25(4):251-257. Acta Paediatr. 2009;98(2):304-309. 2. Eriksen V, Nielsen LH, Klokker M, et al. Follow-up of 5- to 11-year-old children treated for persistent pulmonary hypertension of the newborn. 3. Lipkin PH, Davidson D, Spivak L, et al. Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide. J Pediatr. 2002;140(3):306-310. 4. Data on file. Mallinckrodt Pharmaceuticals. 5. INOMAX [package insert]. Hazelwood, MO: Mallinckrodt Pharmaceuticals; 2015. 6. González A, Fabres J, D’Apremont I, et al. Randomized controlled trial of early compared with delayed use of inhaled nitric oxide in newborns with a moderate respiratory failure and pulmonary hypertension. J Perinatol. 2010;30(6):420-424.